Boston Scientific Corpora... (BSX)
Boston Scientific Statistics
Share Statistics
Boston Scientific has 1.48B shares outstanding. The number of shares has increased by 0.6% in one year.
| 1.48B |
| 0.6% |
| 0.36% |
| 90.6% |
| n/a |
| 6,868 |
| 0.08% |
Short Selling Information
The latest short interest is 16.75M, so 1.13% of the outstanding shares have been sold short.
| 16.75M |
| 1.13% |
| 1.13% |
| 2.77 |
Valuation Ratios
The PE ratio is 70.89 and the forward PE ratio is 31.13. Boston Scientific's PEG ratio is 4.25.
| 70.89 |
| 31.13 |
| 7.85 |
| 5.5 |
| 6.04 |
| 49.69 |
| 4.25 |
Enterprise Valuation
Boston Scientific has an Enterprise Value (EV) of 142.17B.
| 8.49 |
| 36.08 |
| 41.39 |
| 53.75 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 0.51.
| 1.08 |
| 0.64 |
| 0.51 |
| 2.83 |
| 4.21 |
| 8.53 |
Financial Efficiency
Return on Equity is 8.52% and Return on Invested Capital is 6.06%.
| 8.52% |
| 4.71% |
| 6.06% |
| $315,981.13 |
| $34,981.13 |
| 53,000 |
| 0.43 |
| 1.87 |
Taxes
| 436M |
| 19.11% |
Stock Price Statistics
The stock price has increased by 34.88% in the last 52 weeks. The beta is 0.69, so Boston Scientific's price volatility has been higher than the market average.
| 0.69 |
| 34.88% |
| 100.84 |
| 93.85 |
| 47.87 |
| 8,345,371 |
Income Statement
In the last 12 months, Boston Scientific had revenue of 16.75B and earned 1.85B in profits. Earnings per share was 1.26.
| 16.75B |
| 11.49B |
| 2.6B |
| 1.85B |
| 3.94B |
| 2.59B |
| 1.26 |
Balance Sheet
The company has 414M in cash and 11.15B in debt, giving a net cash position of -10.73B.
| 414M |
| 11.15B |
| -10.73B |
| 2.67B |
| 40.14B |
| 2.28B |
Cash Flow
In the last 12 months, operating cash flow was 3.44B and capital expenditures -790M, giving a free cash flow of 2.65B.
| 3.44B |
| -790M |
| 2.65B |
| 1.8 |
Margins
Gross margin is 68.61%, with operating and profit margins of 15.54% and 11.07%.
| 68.61% |
| 15.54% |
| 13.63% |
| 11.07% |
| 23.53% |
| 15.54% |
| 15.79% |
Dividends & Yields
BSX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| 1.41% |
| 2.01% |
Analyst Forecast
The average price target for BSX is $117, which is 14% higher than the current price. The consensus rating is "Buy".
| $117 |
| 14% |
| Buy |
| 21 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| 20.48 |
| -80.05% |
Stock Splits
The last stock split was on Nov 6, 2003. It was a forward split with a ratio of 2:1.
| Nov 6, 2003 |
| forward |
| 2:1 |
Scores
| 6.1 |
| 6 |